Home › Hidradenitis Suppurativa › NCT03967600
Clinical and Biological Characteristics of Hidradenitis Suppurativa
Who can join
Ages 13 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Hidradenitis Suppurativa Patients Inclusion Criteria: 1. Age 13 years or older 2. Diagnosis of HS clinically-confirmed by a physician Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent. Healthy Volunteer Inclusion Criteria: 1. No history of chronic skin conditions 2. No recent history of antibiotic use Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
About the study
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Sponsor: University of California, San Francisco · Participants: 1,000 · Started: Jul 15, 2016
Contact the study team
- Kaelin Chatterley · Phone: 415-961-3786
Official record on ClinicalTrials.gov — NCT03967600
Locations in the U.S.
| California | University of California, San Francisco, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.